US 11110089
Pyridazinones and their use in the treatment of cancer
granted A61KA61K31/501A61K45/06
Quick answer
US patent 11110089 (Pyridazinones and their use in the treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/501, A61K45/06, A61P, A61P35/00